HbA1c: Check at baseline, 6 weeks, 12 weeks, and quarterly thereafter
Lillys Zepbound, approved in November 2023 as the Indiana-based drug giants answer to Novo Nordisks Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase 3 trial, and a mid-stage study of another Lilly experimental medicine, called retatrutide, showed 24% weight loss after just 48 weeks
Patient preference and experience should guide final selection
This includes: Unlimited 1:1 provider consults 24/7 access to your care team Functional nutritional counseling Exclusive mobile app access Is compounded semaglutide right for your weight loss goals?
You will still need a prescription from a medical provider
Medicare can cover it in limited situations tied to another accepted indication, but not as a broad obesity benefit for everyone right now